| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.27 | 0.1 |